Senate Inquiry Calls for Clearer APVMA Rules on Hemp-Based Pet Nutrition
Australian pet wellness pioneer HempPet has welcomed a landmark Senate committee recommendation calling on government regulators to simplify and clarify the regulatory framework surrounding hemp-based pet products.
The Senate Rural and Regional Affairs and Transport References Committee recently released its report, Opportunities for the development of a hemp industry in Australia. Among its key findings, the report highlighted widespread industry confusion regarding product classification, pointing out that shifting interpretations from the Australian Pesticides and Veterinary Medicines Authority (APVMA) have hampered sector growth and created uncertainty for Australian business owners.
A "Quiet Win" for Australian Pets and Business
Recommendation 5 of the Senate report specifically calls on the APVMA to clarify requirements and simplify the process for eligible hemp-based products to be classified as Excluded Nutritional or Digestive (END) products.
END products are animal feed formulations that do not require full APVMA registration as veterinary chemical products—provided they meet strict criteria regarding ingredients, manufacturing standards, labelling, and health claims.
HempPet co-founder Arthur Wajs—who also serves as Treasurer of the Australian Industrial Hemp Alliance and represents the sector on the APVMA’s Veterinary Medicines Working Group—described the Senate report as a vital step forward.
"This is a quiet but important win for Australian pets," said Mr Wajs. "The future of hemp in pet care depends on clarity, not confusion."
Why APVMA Product Classification Matters
The distinction between a general nutritional supplement and a registered veterinary chemical product dictates how hemp formulations are developed, distributed, and marketed across Australia:
✔ For Manufacturers: Clear guidelines outline what ingredients, safety evidence, and labelling are required without forcing low-risk nutritional feeds into costly, lengthy pharmaceutical registration pathways.
✔ For Retailers & Vets: Clear regulatory definitions provide certainty on what products can be legally stocked and recommended to clients.
✔ For Pet Owners: Proper labelling allows consumers to clearly distinguish between daily nutritional feed supplements and clinical veterinary treatments designed to cure or prevent disease.
The Senate report cited evidence presented by HempPet showing that hemp feed supplements had repeatedly been treated as veterinary chemical products by regulators, despite meeting criteria that should qualify them as END products.
What Happens Next?
While Recommendation 5 is a significant milestone, it is not legally binding and does not alter current regulations overnight, nor does it provide a blanket exemption for all hemp products. Any formal change will depend on how the APVMA chooses to implement the committee's guidance in the months ahead.
All eligible products will still be required to meet strict safety, quality, and evidentiary standards before hitting store shelves.
“Pet owners need clear information about what a product is, what it is intended to do, and what claims can legitimately be made about it. This could help them make far better-informed decisions for their pets.” — Arthur Wajs, HempPet
HempPet has confirmed it will continue engaging constructively with government authorities, the APVMA, and industry partners to ensure practical guidance is established while keeping pet safety at the forefront.
About HempPet
HempPet is an Australian-owned pioneer in high-quality, hemp-derived wellness products for companion animals. Working closely with veterinarians, researchers, and pet professionals, HempPet produces a range of premium hemp-based oils, supplements, and treats for dogs and cats. To learn more about their formulations and FAQs, visit hemppet.com.au.






